News Pfizer sues J&J, alleging it blocked access to Remicade bios... J&J used anticompetitive tactics to prevent use of cheaper Inflectra
News Roche under pressure as second rituximab biosimilar filed in... Sandoz is following closely behind rival from Teva and Celltrion.
News Ready to pounce: Samsung joins Amgen with Humira biosimilar ... No-one can launch biosimilars until patent expires next year
News Ablynx and Sanofi sign potential 2.4bn euro R&D deal Collaboration will develop drugs for inflammatory diseases
News Sanofi's RA drug Kevzara approved in Europe Sanofi’s next-generation rheumatoid arthritis drug Kevzara has been approved in Europe, giving a new option for patients who are intolerant to other treatments.
News Moderna jab on trial for cancer-causing syndrome Patients with Lynch syndrome could have a potential treatment on the horizon, as a Moderna mRNA vaccine starts trials at Oxford University.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
